H-1B sponsorMAFEIN 04-3027191Updated Jul 2026
Shire Human Genetic Therapies Inc.
US H-1B Labor Condition Application activity for Shire Human Genetic Therapies Inc.. Filed 286 disclosures between FY2010 and FY2026 from worksites with a MA headquarters indicator.
Total filings
1
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026
H-1B outcome breakdown
Share of Shire Human Genetic Therapies Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 80.8% |
| Cert-withdrawn | 12.6% |
| Withdrawn | 4.5% |
| Denied | 2.1% |
Certified80.8%
Cert-withdrawn12.6%
Withdrawn4.5%
Denied2.1%
Top occupations sponsored
SOC codes filed most by Shire Human Genetic Therapies Inc. across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 15-1252 | Software Developers | 40 |
| 2 | 17-2112 | Industrial Engineers | 38 |
| 3 | 15-1253 | Software Quality Assurance Analysts and Testers | 27 |
| 4 | 19-1022 | Microbiologists | 14 |
| 5 | 13-1151 | Training and Development Specialists | 12 |
| 6 | 11-9199 | Managers, All Other | 12 |
| 7 | 19-1042 | Medical Scientists, Except Epidemiologists | 11 |
| 8 | 13-1041 | Compliance Officers | 9 |
| 9 | 19-2031 | Chemists | 8 |
| 10 | 17-2141 | Mechanical Engineers | 6 |
Software Developers
40
Industrial Engineers
38
Software Quality Assurance Analysts and Testers
27
Microbiologists
14
Training and Development Specialists
12
Managers, All Other
12
Medical Scientists, Except Epidemiologists
11
Compliance Officers
9
Chemists
8
Mechanical Engineers
6
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 15 |
| FY2011 | 15 |
| FY2012 | 19 |
| FY2013 | 13 |
| FY2014 | 28 |
| FY2015 | 12 |
| FY2016 | 19 |
| FY2017 | 27 |
| FY2018 | 42 |
| FY2019 | 31 |
| FY2020 | 15 |
| FY2021 | 13 |
| FY2022 | 2 |
| FY2023 | 5 |
| FY2024 | 21 |
| FY2025 | 8 |
| FY2026 | 1 |
| Period | Value |
|---|---|
| FY2010 | 15 |
| FY2011 | 15 |
| FY2012 | 19 |
| FY2013 | 13 |
| FY2014 | 28 |
| FY2015 | 12 |
| FY2016 | 19 |
| FY2017 | 27 |
| FY2018 | 42 |
| FY2019 | 31 |
| FY2020 | 15 |
| FY2021 | 13 |
| FY2022 | 2 |
| FY2023 | 5 |
| FY2024 | 21 |
| FY2025 | 8 |
| FY2026 | 1 |
Compare Shire Human Genetic Therapies Inc. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Explore by rank
Pre-built leaderboards for the most-asked questions.
Understand the data
Definitions and methodology behind these H-1B figures.